Year: 2026
Type: editorial
Abstract: High Resolution Image Download MS PowerPoint Slide This patent highlight describes the development and evaluation of novel pyridopyrazine analogs as potent inverse agonists for G protein-coupled receptor 6 (GPR6). It discloses synthetic methods and pharmacological properties of these new GPR6 modulators.
Source: ACS Medicinal Chemistry Letters
Authors: Yinlong Li, Steven H. Liang
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: bronze
OpenAlex ID: W7123336549
